TY  - GEN
AU  - Caraglia,M
AU  - Giuberti,G
AU  - Marra,M
AU  - Addeo,R
AU  - Montella,L
AU  - Murolo,M
AU  - Sperlongano,P
AU  - Vincenzi,B
AU  - Naviglio,S
AU  - Prete,S Del
AU  - Abbruzzese,A
AU  - Stiuso,P
TI  - Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
SN  - 2041-4889
PY  - 2011///1101
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Benzenesulfonates
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - blood
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Delayed-Action Preparations
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Leukocytes, Mononuclear
KW  - metabolism
KW  - Liver Neoplasms
KW  - Male
KW  - Mitogen-Activated Protein Kinase 1
KW  - Mitogen-Activated Protein Kinase 3
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Nitric Oxide
KW  - Octreotide
KW  - Oxidative Stress
KW  - Phenylurea Compounds
KW  - Phosphorylation
KW  - Pyridines
KW  - Reactive Oxygen Species
KW  - Sorafenib
KW  - Superoxide Dismutase
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/cddis.2011.34
ER  -